Oral immunotherapy and anti-IgE antibody treatment for food allergy
Open Access
- 1 January 2015
- journal article
- review article
- Published by Elsevier BV in World Allergy Organization Journal
- Vol. 8 (1), 20
- https://doi.org/10.1186/s40413-015-0070-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using OmalizumabAllergy, Asthma & Clinical Immunology, 2014
- IgE-mediated food allergy in childrenThe Lancet, 2013
- Oral Immunotherapy for Food Allergy: Towards a New HorizonAllergy, Asthma & Immunology Research, 2013
- Anaphylaxis in a New York City pediatric emergency department: Triggers, treatments, and outcomesJournal of Allergy and Clinical Immunology, 2012
- A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergyJournal of Allergy and Clinical Immunology, 2011
- Efficacy and safety of high‐dose peanut oral immunotherapy with factors predicting outcomeClinical & Experimental Allergy, 2011
- Food allergyJournal of Allergy and Clinical Immunology, 2010
- Safety of a peanut oral immunotherapy protocol in children with peanut allergyJournal of Allergy and Clinical Immunology, 2009
- A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergyJournal of Allergy and Clinical Immunology, 2008
- Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manualJournal of Allergy and Clinical Immunology, 1988